Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

NCT01290419 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: RSV-F Particle Vaccine
BIOLOGICAL: RSV-F Particle Vaccine
BIOLOGICAL: RSV-F Particle Vaccine
BIOLOGICAL: RSV-F Particle Vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: RSV-F Particle Vaccine
BIOLOGICAL: RSV-F Particle Vaccine

Sponsor

Novavax